Evotec offers services to address therapeutic approaches in the Huntington’s Disease research field e.g. HTT-lowering and somatic instability. The portfolio includes various state-of-the-art technologies from versatile immunoassays for quantification of HTT protein and other HD-relevant biomarkers to integrated PanOmics, extracellular vesicles (EV) platform, HD models, cellular assays and complex readouts.
